Penserra Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $434K | Buy |
|
|||||
|
2025
Q2 | $425K | Sell |
|
|||||
|
2025
Q1 | $670K | Sell |
|
|||||
|
2024
Q4 | $2.25M | Buy |
|
|||||
|
2024
Q3 | $770K | Buy |
|
|||||
|
2024
Q2 | $543K | Buy |
|
|||||
|
2024
Q1 | $60K | Sell |
|
|||||
|
2023
Q4 | $2.16M | Sell |
|
|||||
|
2023
Q3 | $3.25M | Buy |
|
|||||
|
2023
Q2 | $2.4M | Buy |
|
|||||
|
2023
Q1 | $17K | Hold |
|
|||||
|
2022
Q4 | $19K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $3.91M | Buy |
|
|||||
|
2022
Q1 | $34K | Sell |
|
|||||
|
2021
Q4 | $43K | Hold |
|
|||||
|
2021
Q3 | $36K | Buy |
|
|||||
|
2021
Q2 | $33K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $79K | Sell |
|
|||||
|
2020
Q2 | $93K | Sell |
|
|||||
|
2020
Q1 | $103K | Sell |
|
|||||
|
2019
Q4 | $114K | Buy |
|
|||||
|
2019
Q3 | $77K | Buy |
|
|||||
|
2019
Q2 | $46K | Sell |
|
|||||
|
2019
Q1 | $129K | Sell |
|
|||||
|
2018
Q4 | $1.3M | Sell |
|
|||||
|
2018
Q3 | $2M | Buy |
|
|||||
|
2018
Q2 | $337K | Buy |
|
|||||
|
2018
Q1 | $258K | Buy |
|
|||||
|
2017
Q4 | $260K | Buy |
|
|||||
|
2017
Q3 | $224K | Buy |
|
|||||
|
2017
Q2 | $188K | Buy |
|
|||||
|
2017
Q1 | $170K | Buy |
|
|||||
|
2016
Q4 | $135K | Buy |
|
|||||
|
2016
Q3 | $127K | Buy |
|
|||||
|
2016
Q2 | $62K | Buy |
|
|||||
|
2016
Q1 | $38 | Buy |
|
|||||
|
2015
Q4 | $30K | Buy |
|